Literature DB >> 9918589

Chronic ethanol differentially alters susceptibility to chemically induced convulsions in withdrawal seizure-prone and -resistant mice.

D A Finn1, J C Crabbe.   

Abstract

Withdrawal seizure-prone (WSP) and withdrawal seizure-resistant (WSR) mice were selectively bred to have severe (WSP) or mild (WSR) handling-induced convulsions after chronic ethanol inhalation. The purpose of the present experiments was to determine whether seizure susceptibility differences between WSP and WSR mice during ethanol withdrawal were specific to agents acting at gamma-aminobutyric acidA or excitatory amino acid (EAA) receptors. Male WSP and WSR mice were exposed to ethanol vapor or air for 24 or 72 h. During peak withdrawal (i.e., between 6.5 and 8 h after removal from the inhalation chambers), separate groups of animals were administered pentylenetetrazol, (+)bicuculline, N-methyl-D-aspartate, kainic acid, or strychnine via timed tail vein infusion. Withdrawal from ethanol significantly increased sensitivity to pentylenetetrazol and (+)bicuculline versus air-exposed WSP and WSR mice. In contrast, sensitivity to N-methyl-D-aspartate-induced convulsions was significantly decreased in the ethanol-exposed WSR and unchanged in the ethanol-exposed WSP mice. Sensitivity to kainic acid was significantly increased in both ethanol-exposed WSR and WSP mice, although the magnitude of change in sensitivity was greater in the ethanol-withdrawing WSP line. Interestingly, sensitivity to strychnine was decreased similarly in the ethanol-exposed WSP and WSR mice, compared with their respective air-exposed animals. These results suggest that chronic ethanol increased sensitivity to convulsants active at gamma-aminobutyric acidA receptors similarly in WSP and WSR mice, but differentially changed sensitivity to convulsants active at EAA receptors in the lines. This supports a role for EAA systems in determining genetic susceptibility to alcohol withdrawal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918589

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Genotype Differences in Sensitivity to the Anticonvulsant Effect of the Synthetic Neurosteroid Ganaxolone during Chronic Ethanol Withdrawal.

Authors:  Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Neuroscience       Date:  2018-12-02       Impact factor: 3.590

Review 2.  Pharmacogenetic studies of alcohol self-administration and withdrawal.

Authors:  John C Crabbe; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

3.  Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.

Authors:  Paul J Meyer; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2007-07-26       Impact factor: 4.530

4.  Ethanol withdrawal-induced dysregulation of neurosteroid levels in plasma, cortex, and hippocampus in genetic animal models of high and low withdrawal.

Authors:  Jeremiah P Jensen; Michelle A Nipper; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Psychopharmacology (Berl)       Date:  2017-06-29       Impact factor: 4.530

5.  Understanding the addiction cycle: a complex biology with distinct contributions of genotype vs. sex at each stage.

Authors:  C J Wilhelm; J G Hashimoto; M L Roberts; M K Sonmez; K M Wiren
Journal:  Neuroscience       Date:  2014-09-04       Impact factor: 3.590

6.  Running wheel activity protects against increased seizure susceptibility in ethanol withdrawn male rats.

Authors:  Walter D McCulley; Shawn A Walls; Ritu C Khurana; Alan M Rosenwasser; Leslie L Devaud
Journal:  Pharmacol Biochem Behav       Date:  2011-10-20       Impact factor: 3.533

7.  Localization of brain 5α-reductase messenger RNA in mice selectively bred for high chronic alcohol withdrawal severity.

Authors:  Charles E Roselli; Timothy J Finn; Sean M Ronnekleiv-Kelly; Michelle A Tanchuck; Katherine R Kaufman; Deborah A Finn
Journal:  Alcohol       Date:  2011-09-14       Impact factor: 2.405

8.  Local changes in neurosteroid levels in the substantia nigra reticulata and the ventral tegmental area alter chronic ethanol withdrawal severity in male withdrawal seizure-prone mice.

Authors:  Michelle A Tanchuck; Debra K Cozzoli; Ingrid He; Katherine R Kaufman; Christopher Snelling; John C Crabbe; Gregory P Mark; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2012-12-20       Impact factor: 3.455

9.  Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice.

Authors:  Ben Lewis; Dennis J Morrell; Justin M Farook; Ali Krazem; John M Littleton; Susan Barron
Journal:  Physiol Behav       Date:  2008-06-06

10.  Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity.

Authors:  Joel G Hashimoto; Kristine M Wiren
Journal:  Neuropsychopharmacology       Date:  2007-06-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.